| Name | CEP-18770 (Delanzomib) | CAS# | 847499-27-8 | |
|---|---|---|---|---|
| Price | ¥Inquiry/1g | Purity | 98.9% | |
| Stocking Period |
1 Day | Stock | In Stock |
| Detail
Product Information
Delanzomib(CEP-18770) is a novel orally-active inhibitor of the chymotrypsin-like activity of the proteasome that down-modulates the nuclear factor-kappaB (NF-kappaB) activity. |
Get all suppliers by the below link:
CEP-18770 (Delanzomib) suppliers
| 2024-07-15 |
CEP-18770(Delanzomib)
Price: Inquiry |
| 2020-01-06 |
Delanzomib(CEP-18770)
Price: $500.0 |
| 2021-07-26 |
((R)-1-((2S,3R)-3-HYDROXY-2-(6-PHENYLPICOLINAMIDO)BUTANAMIDO)-3-METHYLBUTYL)BORONIC ACID
Price: $Inquiry |
| 2018-04-16 |
CEP-18770
Price: ¥Inquiry |
| 2020-12-08 |
CEP-18770 (Delanzomib)
Price: ¥8200.0 |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved


